Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
Sanders JW, Tang C, Kudchadker RJ, Venkatesan AM, Mok H, Hanania AN, Thames HD, Bruno TL, Starks C, Santiago E, Cunningham M, Frank SJ. Sanders JW, et al. Among authors: thames hd. Brachytherapy. 2023 Nov-Dec;22(6):822-832. doi: 10.1016/j.brachy.2023.08.001. Epub 2023 Sep 15. Brachytherapy. 2023. PMID: 37716820
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center.
Sosa AJ, Rooney MK, Thames HD, Sanders JW, Swanson DM, Choi SL, Nguyen QN, Mok H, Kuban DA, Ron Zhu X, Shah S, Mayo LL, Hoffman KE, Tang C, McGuire SE, Sahoo N, Zhang X, Lee AK, Pugh TJ, Mahmood U, Davis JW, Chapin BF, Corn P, Kudchadker R, Ausat N, Frank SJ. Sosa AJ, et al. Among authors: thames hd. Clin Transl Radiat Oncol. 2024 Jul 31;48:100822. doi: 10.1016/j.ctro.2024.100822. eCollection 2024 Sep. Clin Transl Radiat Oncol. 2024. PMID: 39188999 Free PMC article.
Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences.
Hassanzadeh C, Mohamad O, Bruno T, Wang L, Kudchakar R, Bathala T, Sanders J, Mok H, McGuire S, Kuban D, Hoffman K, Nguyen Q, Park R, Thames H, Corn P, Chapin B, Choi S, Tang C, Frank S. Hassanzadeh C, et al. Brachytherapy. 2025 Jan 3:S1538-4721(24)00445-8. doi: 10.1016/j.brachy.2024.10.015. Online ahead of print. Brachytherapy. 2025. PMID: 39755443
Computer-aided segmentation on MRI for prostate radiotherapy, part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability.
Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Sanders JW, et al. Among authors: thames hd. Radiother Oncol. 2022 Apr;169:132-139. doi: 10.1016/j.radonc.2021.12.033. Epub 2021 Dec 31. Radiother Oncol. 2022. PMID: 34979213
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.
Molkentine DP, Molkentine JM, Bridges KA, Valdecanas DR, Dhawan A, Bahri R, Hefner AJ, Kumar M, Yang L, Abdelhakiem M, Pifer PM, Sandulache V, Sheth A, Beadle BM, Thames HD, Mason KA, Pickering CR, Meyn RE, Skinner HD. Molkentine DP, et al. Among authors: thames hd. Cancer Res. 2022 Mar 1;82(5):916-928. doi: 10.1158/0008-5472.CAN-21-2101. Cancer Res. 2022. PMID: 34965932 Free PMC article.
Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry.
Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Sanders JW, et al. Among authors: thames hd. Radiother Oncol. 2022 Apr;169:124-131. doi: 10.1016/j.radonc.2021.12.011. Epub 2021 Dec 16. Radiother Oncol. 2022. PMID: 34921895
246 results